Enhanced magnetic auditory steady-state response in early Alzheimer's disease

Clinical Neurophysiology

Volumn 117, Issue 9, 2006, Pages 1990-1995

  Osipova, Daria ^a,b,c   Pekkonen, Eero ^a,b   Ahveninen, Jyrki ^d  

^a UNIVERSITY OF HELSINKI   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c Helsinki Brain Research Center   (Finland)

^d MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

Alzheimer's disease; Auditory steady state response; EEG; ERF; ERP; MEG

Indexed keywords

AGED; ALZHEIMER DISEASE; ARTICLE; AUDITORY SYSTEM FUNCTION; BRAIN CORTEX; BRAIN DEPTH STIMULATION; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; EVOKED AUDITORY RESPONSE; EVOKED CORTICAL RESPONSE; FEMALE; HEMISPHERE; HUMAN; MAGNETOENCEPHALOGRAPHY; MALE; PRIORITY JOURNAL; STEADY STATE;

ACOUSTIC STIMULATION; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ANALYSIS OF VARIANCE; BRAIN MAPPING; EVOKED POTENTIALS, AUDITORY; FEMALE; FUNCTIONAL LATERALITY; HUMANS; MAGNETOENCEPHALOGRAPHY; MALE; REACTION TIME; TIME FACTORS;

EID: 33747373165     PISSN: 13882457     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinph.2006.05.034     Document Type: Article

References (47)

1. Ahveninen J., Jääskeläinen I.P., Kaakkola S., Tiitinen H., and Pekkonen E. Aging and cholinergic modulation of the transient magnetic 40-Hz auditory response. Neuroimage 15 (2002) 153-158
2. Ahveninen J., Tiitinen H., Hirvonen J., Pekkonen E., Huttunen J., Kaakkola S., et al. Scopolamine augments transient auditory 40-Hz magnetic response in humans. Neurosci Lett 277 (1999) 115-118
3. Aramakis V.B., Bandrowski A.E., and Ashe J.H. Role of muscarinic receptors, G-proteins, and intracellular messengers in muscarinic modulation of NMDA receptor-mediated synaptic transmission. Synapse 32 (1999) 262-275
4. Basar E., Rosen B., Basar-Eroglu C., and Greitschus F. The associations between 40 Hz-EEG and the middle latency response of the auditory evoked potential. Int J Neurosci 33 (1987) 103-117
5. Bodis-Wollner I. Visual deficits related to dopamine deficiency in experimental animals and Parkinson's disease patients. Trends Neurosci 13 (1990) 296-302
6. Boutros N., Torello M.W., Burns E.M., Wu S.S., and Nasrallah H.A. Evoked potentials in subjects at risk for Alzheimer's disease. Psychiatry Res 57 (1995) 57-63
7. Braak E., Griffing K., Arai K., Bohl J., Bratzke H., and Braak H. Neuropathology of Alzheimer's disease: what is new since A. Alzheimer?. Eur Arch Psychiatry Clin Neurosci 249 (1999) 14-22
8. Broks P., Preston G.C., Traub M., Poppleton P., Ward C., and Stahl S.M. Modeling dementia - effects of scopolamine on memory and attention. Neuropsychologia 26 (1988) 685-700
9. Buchwald J.S., Rubinstein E.H., Schwafel J., and Strandburg R.J. Midlatency auditory evoked responses: differential effects of a cholinergic agonist and antagonist. Electroenceph Clin Neurophysiol 80 (1991) 303-309
10. Cox C.L., Metherate R., and Ashe J.H. Modulation of cellular excitability in neocortex - muscarinic receptor and 2Nd messenger-mediated actions of acetylcholine. Synapse 16 (1994) 123-136
11. Du A.T., Schuff N., Amend D., Laakso M.P., Hsu Y.Y., Jagust W.J., et al. Magnetic resonance imaging of the entorhinal cortex and hippocampus in mild cognitive impairment and Alzheimer's disease. J Neurol Neurosurg Psychiatry 71 (2001) 441-447
12. Durieux M.E. Muscarinic signaling in the central nervous system - recent developments and anesthetic implications. Anesthesiology 84 (1996) 173-189
13. Ebert U., and Kirch W. Review - Scopolamine model of dementia: electroencephalogram findings and cognitive performance. Eur J. Clin. Investig. 28 (1998) 944-949
14. Eggermont J.J. Firing rate and firing synchrony distinguish dynamic from steady state sound. Neuroreport 8 (1997) 2709-2713
15. Folstein M.F., Folstein S.E., and Mchugh P.R. Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12 (1975) 189-198
16. Franowicz M.N., and Barth D.S. Comparison of evoked potentials and high-frequency (gamma-band) oscillating potentials in rat auditory cortex. J Neurophysiol 74 (1995) 96-112
17. Freedman R., Coon H., MylesWorsley M., OrrUrtreger A., Olincy A., Davis A., et al. Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus. Proc Natl Acad Sci USA 94 (1997) 587-592
18. Frisoni G.B., Laakso M.P., Beltramello A., Geroldi C., Bianchetti A., Soininen H., et al. Hippocampal and entorhinal cortex atrophy in frontotemporal dementia and Alzheimer's disease. Neurology 52 (1999) 91-100
19. Galambos R., Makeig S., and Talmachoff P.J. A 40-Hz auditory potential recorded from the human scalp. Proc Natl Acad Sci USA 78 (1981) 2643-2647
20. Golob E.J., Johnson J.K., and Starr A. Auditory event-related potentials during target detection are abnormal in mild cognitive impairment. Clin Neurophysiol 113 (2002) 151-161
21. Green J.B., Flagg L., Freed D.M., and Schwankhaus J.D. The middle latency auditory evoked potential may be abnormal in dementia. Neurology 42 (1992) 1034-1036
22. Gutschalk A., Patterson R.D., Uppenkamp S., Scherg M., and Rupp A. Recovery and refractoriness of auditory evoked fields after gaps in click trains. Eur J Neurosci 20 (2004) 3141-3147
23. Hämäläinen M., Hari R., Ilmoniemi R.J., Knuutila J., and Lounasmaa O.V. Magnetoencephalography-theory, instrumentation, and applications to noninvasive studies of the working human brain. Rev Mod Phys 65 (1993) 413-497
24. Hanyu H., Sakurai H., Iwamoto T., Takasaki M., Shindo H., and Abe K. Diffusion-weighted MR imaging of the hippocampus and temporal white matter in Alzheimer's disease. J Neurol Sci 156 (1998) 195-200
25. Hari R., Hämäläinen M., and Joutsiniemi S.L. Neuromagnetic steady-state responses to auditory stimuli. J Acoust Soc Am 86 (1989) 1033-1039
26. Hasher L., and Zacks R.T. Working memory, comprehension, and aging: a review and a new view. In: Bower G.H. (Ed). The psychology of learning and motivation (1988), Academic Press, New York, NY 193-225
27. Hu B. Functional organization of lemniscal and nonlemniscal auditory thalamus. Exp Brain Res 153 (2003) 543-549
28. Hudspeth A.J. Hearing. In: Kandel E.R., Schwarts J.H., and Jessell T.M. (Eds). Principles of neural science (2000), McGraw Hill and Co., New York 590-612
29. Jääskeläinen I.P., Hirvonen J., Huttunen J., Kaakkola S., and Pekkonen E. Scopolamine enhances middle-latency auditory evoked magnetic fields. Neurosci Lett 259 (1999) 41-44
30. Jack C.R., Petersen R.C., Xu Y., O'Brien P.C., Smith G.E., Ivnik R.J., et al. Rates of hippocampal atrophy correlate with change in clinical status in aging and AD. Neurology 55 (2000) 484-489
31. Joliot M., Ribary U., and Llinas R. Human oscillatory brain activity near 40 Hz coexists with cognitive temporal binding. Proc Natl Acad Sci USA 91 (1994) 11748-11751
32. Lerch J.P., Pruessner J.C., Zijdenbos A., Hampel H., Teipel S.J., and Evans A.C. Focal decline of cortical thickness in Alzheimer's disease identified by computational neuroanatomy. Cereb Cortex 15 (2005) 995-1001
33. Mäkelä J.P., and Hari R. Evidence for cortical origin of the 40 Hz auditory evoked response in man. Electroenceph clin Neurophysiol 66 (1987) 539-546
34. McKhann G., Drachman D., Folstein M., Katzman R., Price D., and Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of department of health and human services task force on Alzheimer's Disease. Neurology 34 (1984) 939-944
35. Nelken I., Fishbach A., Las L., Ulanovsky N., and Farkas D. Primary auditory cortex of cats: feature detection or something else?. Biol Cybern 89 (2003) 397-406
36. O'Mahony D., Rowan M., Feely J., Walsh J.B., and Coakley D. Primary auditory pathway and reticular activating system dysfunction in Alzheimer's disease. Neurology 44 (1994) 2089-2094
37. Pantev C., Elbert T., Makeig S., Hampson S., Eulitz C., and Hoke M. Relationship of transient and steady-state auditory evoked fields. Electroenceph clin Neurophysiol 88 (1993) 389-396
38. Pekkonen E., Hirvonen J., Jääskeläinen I.P., Kaakkola S., and Huttunen J. Auditory sensory memory and the cholinergic system: implications for Alzheimer's disease. Neuroimage 14 (2001) 376-382
39. Pekkonen E., Jääskeläinen I.P., Hietanen M., Huotilainen M., Näätänen R., Ilmoniemi R.J., et al. Impaired preconscious auditory processing and cognitive functions in Alzheimer's disease. Clin Neurophysiol 110 (1999) 1942-1947
40. Pekkonen E., Jousmäki V., Kononen M., Reinikainen K., and Partanen J. Auditory sensory memory impairment in Alzheimer's disease: an event-related potential study. Neuroreport 5 (1994) 2537-2540
41. Pirch J. Electrophysiological effects of acetylcholine on central neurons. In: Stone T. (Ed). CNS neurotransmitters and neuromodulators: Acetylcholine (1995), CRC Press, Boca Raton, FL 115-128
42. Rose S.E., Chen F., Chalk J.B., Zelaya F.O., Strugnell W.E., Benson M., et al. Loss of connectivity in Alzheimer's disease: an evaluation of white matter tract integrity with colour coded MR diffusion tensor imaging. J Neurol Neurosurg Psychiatry 69 (2000) 528-530
43. Shute C.C.D., and Lewis P.R. Ascending cholinergic reticular system: neocortical, olfactory and subcortical projections. Brain 90 (1967) 497
44. Sunderland T., Tariot P.N., Weingartner H., Murphy D.L., Newhouse P.A., Mueller E.A., et al. Pharmacological modeling of Alzheimer's disease. Prog Neuropsychopharmacol Biol Psychiatry 10 (1986) 599-610
45. Terry R.D., Masliah E., and Hansen L. The neuropathology of Alzheimer disease and structural basis of its cognitive alterations. In: Terry R.D., Katzman R., Bick K.L., and Sisodia S.S. (Eds). Alzheimer disease (1999), Lippincott Williams & Wilkins, Baltimore 187-206
46. Thompson P.M., Hayashi K.M., Sowell E.R., Gogtay N., Giedd J.N., Rapoport J.L., et al. Mapping cortical change in Alzheimer's disease, brain development, and schizophrenia. Neuroimage 23 (2004) S2-S18
47. Tobimatsu S., Hamada T., Okayama M., Fukui R., and Kato M. Temporal frequency deficit in patients with senile dementia of the Alzheimer type: a visual evoked potential study. Neurology 44 (1994) 1260-1263